VACCINATION SITE CELLULITIS

This adverse event was reported 26 times

VACCINATION SITE CELLULITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 2 0.0011
1 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
2 ELOTUZUMAB 1 0.0002
3 CLINDAMYCIN PHOSPHATE 1 0.0002
4 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE 1 0.0001
5 BUSPIRONE HYDROCHLORIDE 1 0.0001
6 PROGESTERONE 1 0.0000
7 DESVENLAFAXINE SUCCINATE 1 0.0000
8 CARFILZOMIB 1 0.0000
9 ROSUVASTATIN CALCIUM 1 0.0000
See all drugs enriched for association with VACCINATION SITE CELLULITIS

VACCINATION SITE CELLULITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 2 0.0011
1 SLAMF7-directed Immunostimulatory Antibody [EPC] 1 0.0002
2 Barbiturate [EPC] 1 0.0001
3 Progesterone [EPC] 1 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Sympathomimetic-like Agent [EPC] 1 0.0000
6 Complement Inhibitor [EPC] 1 0.0000
7 Methylxanthine [EPC] 1 0.0000
8 Integrin Receptor Antagonist [EPC] 1 0.0000
9 Anti-IgE [EPC] 1 0.0000
See all drug classes enriched for association with VACCINATION SITE CELLULITIS